Evaluation of the PHENO4U Data Platform in Patients Undergoing Total Knee Arthroplasty

Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorAesculap AG

About this trial

Prospective, multinational pilot study for evaluation of the Pheno4U data platform in Total Knee Arthroplasty (TKA) patients

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

Patient undergoing a total knee arthroplasty with a B. Braun knee implant system

Signed written informed consent

Patient's willingness & ability to use the "BPMpathway"sensor

Patient's willingness & ability to use the "4Patient" application

Disqualifiers

Patient age < 18 years

Patient not willing to participate at the further follow-up

Pregnancy

If intraoperatively an implant from a different manufacturer is used, the study patient has to be excluded from the study.

Trial population

Patients will be recruited consecutively. No selection besides the inclusion and exclusion criteria will take place. Four different TKA implant systems can be used within the study: Columbus, E.motion, Enduro and VEGA according to the instructions for use.

Trial design

Design model

Cohort

Time perspective

Prospective

Treatments tested in this trial

  • Pheno4U

    Device

    Total Knee Arthroplasty represents a well-established, reliable and successful treatment option for end-stage bicompartmental osteoarthritis or other indications resulting in joint destruction. In general, Implantation of a total knee prosthesis improves the quality of life through pain alleviation, deformity correction, joint stabilization, and/or functional range of motion (ROM) through restoration of normal knee kinematics and functionality

Treatment groups

600 Participants
are divided into 1 treatment group
Group A: Pheno4U1 intervention

Trial outcomes

Primary outcomes

1

Identification of any unknown risks or side effects in Total Knee Arthroplasty by using sensors and patient apps

The study will collect data for each patient receiving an Aesculap TKA implant. The data set will be analyzed for critical risk factors among implant and patient data in order to optimize patient-centered therapies

Time frame
up to 12 months postoperatively

Secondary outcomes

1

Change of Knee Injury and Osteoarthritis Outcome score

The Patient self-assessed Injury and Knee Osteoarthritis Outcome Scores (KOOS) is a joint-specific instrument: The KOOS evaluates both short-term and long-term consequences of knee injury. It holds 42 items in 5 separately scored subscales; Pain, other Symptoms, Function in daily living (ADL), Function in Sport and Recreation (Sport/Rec), and knee-related Quality of Life (QOL). The score is a percentage score from 0 to 100, 0 representing extreme problems and 100 representing no problems.

Time frame
2 weeks prior to surgery, 6 weeks postoperatively and approximately 1 year after surgery
2

Change of Hospital for Special Surgery (HSS) Knee Surgery Expectations Survey

The Hospital for Special Surgery (HSS) Knee Surgery Expectations Survey is a 17 item questionnaire. The survey is comprised of five different categories of expectations: pain, walking, psychological state, essential activities and non-essential activities. The responses range from ''very important'' (score: 1) to ''this does not imply to me'' (score: 5). The total summed raw score ranges from 0 to 76 and the transformed score \[ = (raw score/76)×100\] ranges from 0 to 100. Higher scores indicate expecting more improvement for more items.

Time frame
2 weeks prior to surgery, 6 weeks postoperatively and approximately 1 year after surgery
3

Change of Pain

Information on pain is collected by the so called "painDETECT" questionnaire, a self-reported screening tool for the identification of neuropathic pain. The questionnaire contains seven weighted sensory descriptors, one item relating to spatial pain characteristics and one item relating to temporal characteristics. A total score ranging from -1 to 38 can be calculated. The total score is divided into three categories (unlikely neuropathic pain (\<13), unclear (13-18), likely neuropathic pain (\>18)).

Time frame
2 weeks prior to surgery, 6 weeks postoperatively and approximately 1 year after surgery
4

Patient satisfaction

Based on a single question 9 months after surgery patients are asked to grade their level of satisfaction with the methodology and rehabilitation procedure. They can choose between "very dissatisfied", "dissatisfied", "satisfied" or "very satisfied".

Time frame
approximately 9 months after surgery

Other outcomes

1

Cumulative Radiological Evaluation

Imaging will be used to evaluate the implant status as well as device condition and potential presence of device-related Adverse Events including fracture, wear, loosening or radiolucencies.

Time frame
for each x-ray taken in clinical routine up to last follow-up approximately 12 months postoperatively
2

Cumulative Rate of (Serious) Adverse Events

During the course of the study any upcoming intra- or postoperative (serious) adverse events directly or possibly related to the products under investigation will be documented in the dedicated electronic case report forms (eCRFs). Recorded complications will be categorized and analyzed in order to assess the safety of the investigational products.

Time frame
up to last follow-up approximately 12 months postoperatively

Sponsors and contacts

Click on the lead sponsor to view all of their trials.